Navigation Links
BMC awarded contract to study validity of primary care drug screening tools
Date:7/23/2012

(Boston) - Boston Medical Center (BMC) has been awarded a contract from the Mitre Corporation for approximately $173,000 for six months to test the validity of a self-administered screening tool to detect drug use in primary care patients.

Awarded as part of the White House Office of the National Coordinator for Health Information Technology (ONCHIT) efforts toward meaningful use of electronic health records, the contract will allow researchers to test self-administered screening tools to identify illicit drug use. After determining the best method, it will be a candidate for dissemination for use in electronic health records nationally.

In the study, research assistants from Boston University School of Medicine and Public Health will administer questions about drug use to the 200 enrolled participants using a computer tablet followed by a more detailed assessment by interview.

BMC Internal Medicine Physician, Richard Saitz, MD, Principal Investigator of the study anticipates that a single self-administered question will perform well and will detect most people who are using drugs. According to Saitz, the same method is being used for a single item that identifies heavy alcohol use, which has been successful in identifying people with unhealthy alcohol use. Although single-item questions for drug and alcohol use have been validated, the study will focus on the validity of questions for self-administration, as might be done in a doctors' office waiting room.

"It is increasingly important for clinicians to identify patients using drugs so that they can be given appropriate advice and counseling to prevent negative health consequences," said Saitz, who is a professor of medicine and epidemiology at Boston University School of Medicine and Public Health. "Having patients answer self-administered questions by computer or even on paper is more practical and efficient than being interviewed by a clinician in a busy health-care practice setting."


'/>"/>
Contact: Gina Orlando
gina.orlando@bmc.org
617-638-8490
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
2. $9 million grant awarded to UH to study, treat learning disabilities
3. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
4. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
5. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
6. Southeast program to fight diabetes awarded nearly $10 million by HHS
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. 29 Johns Hopkins stem cell researchers awarded funding
9. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. EMBO Gold Medal 2012 awarded to Jiri Friml
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: